Waverley Pharma Inc. (FRA:5GZ)

Waverley Pharma Revenue

Waverley Pharma had revenue of 275.66K CAD in the quarter ending September 30, 2025, with 1,129.68% growth. This brings the company's revenue in the last twelve months to 1.51M, up 2,016.26% year-over-year. In the year 2024, Waverley Pharma had annual revenue of 475.37K with 15.36% growth.

• Revenue (ttm): 1.51M CAD
• Revenue Growth: +2,016.26%
• P/S Ratio: 0.54
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 497.75K EUR

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	475.37K	63.28K	15.36%
Dec 31, 2023	412.09K	-834.74K	-66.95%
Dec 31, 2022	1.25M	-506.02K	-28.87%
Dec 31, 2021	1.75M	377.74K	27.47%
Dec 31, 2020	1.38M	217.83K	18.82%